In addition to the well-established CXCR3 pathway58, several studies have shown the chemotactic effect of the CCL2-CCR2 and CCL22-CCR4 axes on CTLs in vitro79–83 and in vivo, partially with an overall anti-tumor effect56,57,84–86. The gene discussed is CXCR3; the disease is neoplasm.